This article reviews the role of chronic toxic metal exposure in cardiovascular disease (CVD), highlighting the impact of metal chelation therapy, particularly using edetate disodium, as a secondary prevention method for cardiovascular events. It discusses the findings of the Trial to Assess Chelation Therapy (TACT), which demonstrated that chelation therapy
